glp-1 agonists pills for weight loss medications New GLP-1 Pill Foundayo (Orforglipron)

(2025) Tirzepatide for heart failure with preserved ejection fraction and obesity

A recent prospective study, which analyzed data from 237 patients with T2D, followed by nearly 5 years with elastography, suggested that SGLT2 inhibitors reduced the risk of worsening liver stiffness [102]

Hidayat K, Du X, Shi BM

doi: 10.1210/en.2016-1755

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Wolfe M.M., Boylan M.O., Chin WW

Although diabetes is widely accepted as one of the major risk factors for cardiovascular disease, the cardiovascular safety of antidiabetic drugs has been questioned due to the finding that intensive glycemic control by antidiabetic medications may result in an unexpected increase in cardiovascular death under certain circumstances [6]